Side-by-side comparison of AI visibility scores, market position, and capabilities
Affordable cord blood and tissue banking with FDA-registered storage for broader stem cell access; $4.62M from Seven Seven Six and YC at $1.8M revenue competing with CBR for expectant parent insurance market.
Anja Health is a San Jose-based cord blood and cord tissue banking company that makes stem cell preservation from newborn births accessible and affordable — providing nationwide FDA-registered collection and storage of umbilical cord blood and cord tissue that contain hematopoietic stem cells and mesenchymal stem cells, which may be used in future treatments for blood disorders, immune conditions, and emerging regenerative medicine applications. Founded in 2021 and backed by Alexis Ohanian's Seven Seven Six fund and Y Combinator with $4.62 million raised including a $2 million seed round in May 2024, Anja Health achieved $1.8 million in revenue as of December 2024.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.